发明名称 Use of low molecular weight thrombin inhibitors in cholesterol-lowering therapy
摘要 According to the invention there is provided a cholesterol lowering therapy method and a method for modification of lipid (triglyceride), lipoprotein, and apolipoprotein profiles associated with an increased risk of cardiovascular complications comprising the administration of a low molecular weight thrombin inhibitor, or a pharmaceutically acceptable derivative thereof, to a patient in need thereof.
申请公布号 ZA200507614(B) 申请公布日期 2006.06.28
申请号 ZA20050007614 申请日期 2005.09.20
申请人 ASTRAZENECA AB 发明人 MARGARETHA GRIND
分类号 A61K;A61K6/00;A61K31/397;A61K31/40;A61K38/05;A61P;A61P3/06;A61P3/10;A61P7/02 主分类号 A61K
代理机构 代理人
主权项
地址